PSYENCE BIOMEDICAL LTD. - PBM
Detailed investor-level table based on 13F positions.
Methodology:
Market value and % of portfolio use SEC reported VALUE ($000).
For PUT/CALL positions this reflects reported underlying exposure, not premium cash paid/received.
Details.
Rows: 0
| Investor | History | Status | Shares held | Market value ($000) | % of portfolio | Previous % | Rank | Change in shares | % change in shares | Source | Date reported |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CANTOR FITZGERALD, L. P. | History | No change | 337,000 | 33 | 0.0% | 0.02% | 1 | 0 | 0.0% | Q3 2024 | Nov 14, 2024 |
| CITADEL ADVISORS LLC | History | New | 169,251 | 16 | 0.0% | — | 2 | +169,251 | New | Q3 2024 | Nov 14, 2024 |
| JANE STREET GROUP, LLC | History | New | 45,963 | 4 | 0.0% | — | 4 | +45,963 | New | Q3 2024 | Nov 15, 2024 |
| MORGAN STANLEY | History | Added to | 48,407 | 4 | 0.0% | 0.0% | 3 | +28,407 | 142.04% | Q3 2024 | May 14, 2025 |
| Tower Research Capital LLC (TRC) | History | New | 34,391 | 3 | 0.0% | — | 5 | +34,391 | New | Q3 2024 | Nov 14, 2024 |
| UBS Group AG | History | Reduced | 15,030 | 1 | 0.0% | 0.0% | 7 | -7,855 | -34.32% | Q3 2024 | Nov 14, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | History | No change | 10,488 | 1 | 0.0% | 0.0% | 6 | 0 | 0.0% | Q3 2024 | Nov 12, 2024 |
| JPMORGAN CHASE & CO | History | No change | 2 | 0 | — | — | — | 0 | 0.0% | Q3 2024 | Nov 08, 2024 |